Journey Medical Corporation, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in dermatology and other therapeutic areas. Founded in 2016, the company has rapidly established itself through strategic partnerships and innovative product offerings, focusing on the development and commercialisation of prescription medications. With a diverse portfolio that includes unique formulations and delivery systems, Journey Medical aims to address unmet medical needs in skin health and beyond. The company’s commitment to quality and efficacy has positioned it as a trusted name among healthcare professionals. Notable achievements include a growing market presence and recognition for its contributions to dermatological care, underscoring its role as a leader in the industry.
How does Journey Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Journey Medical Corporation's score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Journey Medical Corporation, headquartered in the US, currently does not have specific carbon emissions data available for reporting. As a current subsidiary of Fortress Biotech, Inc., any emissions data would be inherited from this parent company. However, there are no documented reduction targets or climate pledges from Journey Medical Corporation itself. In the context of climate commitments, the absence of specific emissions data suggests that Journey Medical Corporation may still be in the early stages of developing its sustainability strategy. The company has not publicly outlined any significant reduction initiatives or targets, which may reflect a broader trend within the industry as organisations increasingly focus on establishing measurable climate goals. As the landscape of corporate climate responsibility evolves, it is essential for companies like Journey Medical Corporation to consider adopting industry-standard frameworks such as the Science Based Targets initiative (SBTi) to enhance their climate commitments and transparency.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Journey Medical Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.